{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:53:48Z","timestamp":1785210828274,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["DIR \/ WK \/ 2018\/06"],"award-info":[{"award-number":["DIR \/ WK \/ 2018\/06"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["24.10.2018"],"award-info":[{"award-number":["24.10.2018"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113473","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T14:15:21Z","timestamp":1659363321000},"page":"113473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Chiral sulfonamides with various N-heterocyclic and aromatic units \u2013 Synthesis and antiviral activity evaluation"],"prefix":"10.1016","volume":"153","author":[{"given":"Dominika","family":"Iwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Denel-Bobrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka B.","family":"Olejniczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Wojaczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113473_bib1","series-title":"Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics","article-title":"Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections","author":"Petri","year":"2011"},{"key":"10.1016\/j.biopha.2022.113473_bib2","first-page":"128","article-title":"The use of sodium sulfacetamide in dermatology","volume":"96","author":"Wolf","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.biopha.2022.113473_bib3","doi-asserted-by":"crossref","unstructured":"R. Bentley, Different roads to discovery; Prontosil (hence sulfa drugs) and penicillin (hence \u03b2-lactams), J. Ind. Microbiol. Biotechnol., 2009, 36, 775\u2013786. \u3008https:\/\/doi.org\/10.1007\/s10295\u2013009-0553\u20138\u3009.","DOI":"10.1007\/s10295-009-0553-8"},{"key":"10.1016\/j.biopha.2022.113473_bib4","first-page":"1","article-title":"Sulfonamides: historical discovery development (structure-activity relationship notes)","volume":"1","author":"Yousef","year":"2018","journal-title":"In-Vitro In-vivo In-silico J."},{"key":"10.1016\/j.biopha.2022.113473_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867033457647","article-title":"Anticancer and antiviral sulfonamides","volume":"10","author":"Scozzafava","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113837","article-title":"Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation","volume":"226","author":"Wan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib7","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1021\/acs.jafc.9b02681","article-title":"Synthesis, antiviral activity, and mechanisms of purine nucleoside derivatives containing a sulfonamide moiety","volume":"67","author":"He","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib8","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.bmcl.2006.04.011","article-title":"Lysine sulfonamides as novel HIV-protease inhibitors: N\u03b5-Acyl aromatic \u03b1-amino acids","volume":"16","author":"Stranix","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.113473_bib9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/acsmedchemlett.7b00386","article-title":"Design and synthesis of piperazine sulfonamide cores leading to highly potent HIV-1 protease inhibitors","volume":"8","author":"Bungard","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.113473_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/14756366.2016.1221826","article-title":"Identification and inhibition of carbonic anhydrases from nematodes","volume":"31","author":"Zolfaghari Emameh","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib11","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib12","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.3390\/ma13215010","article-title":"Biaryl sulfonamides based on the 2-azabicycloalkane skeleton\u2014synthesis and antiproliferative activity","volume":"13","author":"Iwan","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.biopha.2022.113473_bib13","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3390\/molecules25102355","article-title":"Synthesis and cytotoxic activity of chiral sulfonamides based on the 2-azabicycloalkane skeleton","volume":"25","author":"Samadaei","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.113473_bib14","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.tet.2012.07.028","article-title":"Novel chiral bridged azepanes: stereoselective ring expansion of 2-azanorbornan-3-yl methanols","volume":"68","author":"Wojaczy\u0144ska","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.biopha.2022.113473_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/adsc.200404098","article-title":"N-Arenesulfonyl-2-aminomethylpyrrolidines novel modular ligands and organocatalysts for asymmetric catalysis","volume":"346","author":"Dahlin","year":"2004","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.biopha.2022.113473_bib16","unstructured":"J.H. Lazerwith , S.E. Martin , T.A.T. Bacon , E.M. Cottell , J.J. Cai , Z.R. Pyun , H. Morganelli , P.A. Ji , M. Taylor , et al., Polycyclic-carbamoylpyridone compounds and their pharmaceutical use, U.S. Patent 14\/133,858, 26 June 2014."},{"key":"10.1016\/j.biopha.2022.113473_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.tetasy.2016.06.009","article-title":"Synthesis, structure and antiproliferative activity of chiral polyamines based on a 2-azanorbornane skeleton","volume":"27","author":"Kami\u0144ska","year":"2016","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.biopha.2022.113473_bib18","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1039\/C6NJ02251K","article-title":"Zinc complexes formed by 2,2\u2032-bipyridine and 1,10-phenanthroline moieties combined with 2-azanorbornane: modular chiral catalysts for aldol reactions","volume":"40","author":"Wojaczy\u0144ska","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1039\/b414742a","article-title":"Organocatalysis with proline derivatives: improved catalysts for the asymmetric Mannich, nitro-Michael and aldol reactions","volume":"3","author":"Cobb","year":"2005","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib20","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1016\/j.bmc.2005.04.042","article-title":"Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates","volume":"13","author":"Le\u015bnikowski","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib21","first-page":"489","article-title":"Modification of selected anti-HCMV drugs with lipophilic boron cluster modulator","volume":"70","author":"Olejniczak","year":"2013","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.biopha.2022.113473_bib22","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1016\/S0040-4039(00)70675-7","article-title":"Stereoselective synthesis of pipecolic acid derivatives using aza-Diels-Alder reactions","volume":"30","author":"Bailey","year":"1989","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biopha.2022.113473_bib23","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/0040-4039(90)80136-A","article-title":"Asymmetric aza-Diels-Alder reaction using the chiral 1-phenyl ethyl imine of methyl glyoxylate","volume":"31","author":"Stella","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biopha.2022.113473_bib24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jlac.1991199101180","article-title":"Asymmetric synthesis of bicyclic amino acid derivatives by aza-Diels-Alder reactions in aqueous solution","author":"Waldmann","year":"1991","journal-title":"Liebigs Ann. Chem."},{"key":"10.1016\/j.biopha.2022.113473_bib25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0957-4166(95)00151-E","article-title":"Synthesis of new chiral catalysts, N-alkyl-2-azanorbornyl-methanols, for the enantioselective addition of diethylzinc to arylaldehydes","volume":"6","author":"Nakano","year":"1995","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.biopha.2022.113473_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0957-4166(02)00127-1","article-title":"Multigram scale synthesis of a useful aza-Diels\u2013Alder adduct in a one-step procedure","volume":"13","author":"Ekegren","year":"2002","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.biopha.2022.113473_bib27","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1021\/bi048211u","article-title":"NH-Dansyl isocolchicine exhibits a significantly improved tubulin-binding affinity and microtubule inhibition in comparison to isocolchicine by binding tubulin through Its A and B rings","volume":"44","author":"Das","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2022.113473_bib28","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/cmdc.201000282","article-title":"Dansyl C -glucoside as a novel agent against endotoxic shock","volume":"5","author":"La Ferla","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2022.113473_bib29","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3390\/ma13204574","article-title":"Hyperbranched polymers modified with dansyl units and their Cu(II) complexes. bioactivity studies","volume":"13","author":"Bosch","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.biopha.2022.113473_bib30","series-title":"Cytotoxicity","article-title":"Role of cytotoxicity experiments in pharmaceuticals development","author":"B\u00e1cskay","year":"2017"},{"key":"10.1016\/j.biopha.2022.113473_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.podrm.2020.07.005","article-title":"Chapter six - validation of in-vitro bioassay methods: Application in herbal drug research","volume":"46","author":"Indrayanto","year":"2021","journal-title":"Profiles Drug Subst. Excip. Relat. Method."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222008629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222008629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:36:41Z","timestamp":1779968201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222008629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":31,"alternative-id":["S0753332222008629"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113473","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chiral sulfonamides with various N-heterocyclic and aromatic units \u2013 Synthesis and antiviral activity evaluation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113473"}}